Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
Women with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been bo...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/full |
id |
doaj-cd166cebbee546fd9965b8afd380cbbb |
---|---|
record_format |
Article |
spelling |
doaj-cd166cebbee546fd9965b8afd380cbbb2021-01-15T11:28:16ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-01-011110.3389/fendo.2020.593718593718Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue CryopreservedLinn Salto Mamsen0Stine Gry Kristensen1Susanne Elisabeth Pors2Jane Alrø Bøtkjær3Erik Ernst4Kirsten Tryde Macklon5Debra Gook6Debra Gook7Ajay Kumar8Bhanu Kalra9Claus Yding Andersen10Laboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkDepartment of Obstetrics and Gynaecology, Regional Hospital Horsens, Horsens, DenmarkThe Fertility Clinic, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkReproductive Services and Melbourne IVF, Royal Women’s Hospital, Parkville, VIC, AustraliaDepartment of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, AustraliaAnsh Labs LLC, Webster, TX, United StatesAnsh Labs LLC, Webster, TX, United StatesLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkWomen with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been born after successful OTC and transplantation. We evaluated follicle number and follicle health in ovarian tissue from a cohort of BT and SCD patients who underwent OTC before the age of 18 years. Patients undergoing OTC from 2002 to 2019 were included. A total of 14 girls and adolescents with BT and four with SCD, aged 2.8–17.4 years at OTC were included together with a reference group of 43 girls and adolescents with non-anemia diseases considered to have normal ovaries aged 0.6–17.9 years at OTC. Ovarian follicle density was measured in cortex biopsies and compared to the reference group. Expression of proteins associated with follicular health was evaluated using immunohistochemistry. Follicles were detected in the ovarian cortex biopsies from all patients with BT and SCD. The follicle densities were within the 95% prediction interval of the reference group in all cases. A similar expression of six proteins essential for follicular health was detected using immunohistochemistry in BT, SCD, and references. OTC should be considered an option for young girls and adolescents with BT and SCD.https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/fullovarian tissue cryopreservationfertility preservationthalassemiasickle cell diseasegenetic diseases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Linn Salto Mamsen Stine Gry Kristensen Susanne Elisabeth Pors Jane Alrø Bøtkjær Erik Ernst Kirsten Tryde Macklon Debra Gook Debra Gook Ajay Kumar Bhanu Kalra Claus Yding Andersen |
spellingShingle |
Linn Salto Mamsen Stine Gry Kristensen Susanne Elisabeth Pors Jane Alrø Bøtkjær Erik Ernst Kirsten Tryde Macklon Debra Gook Debra Gook Ajay Kumar Bhanu Kalra Claus Yding Andersen Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved Frontiers in Endocrinology ovarian tissue cryopreservation fertility preservation thalassemia sickle cell disease genetic diseases |
author_facet |
Linn Salto Mamsen Stine Gry Kristensen Susanne Elisabeth Pors Jane Alrø Bøtkjær Erik Ernst Kirsten Tryde Macklon Debra Gook Debra Gook Ajay Kumar Bhanu Kalra Claus Yding Andersen |
author_sort |
Linn Salto Mamsen |
title |
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved |
title_short |
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved |
title_full |
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved |
title_fullStr |
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved |
title_full_unstemmed |
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved |
title_sort |
consequences of β-thalassemia or sickle cell disease for ovarian follicle number and morphology in girls who had ovarian tissue cryopreserved |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2021-01-01 |
description |
Women with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been born after successful OTC and transplantation. We evaluated follicle number and follicle health in ovarian tissue from a cohort of BT and SCD patients who underwent OTC before the age of 18 years. Patients undergoing OTC from 2002 to 2019 were included. A total of 14 girls and adolescents with BT and four with SCD, aged 2.8–17.4 years at OTC were included together with a reference group of 43 girls and adolescents with non-anemia diseases considered to have normal ovaries aged 0.6–17.9 years at OTC. Ovarian follicle density was measured in cortex biopsies and compared to the reference group. Expression of proteins associated with follicular health was evaluated using immunohistochemistry. Follicles were detected in the ovarian cortex biopsies from all patients with BT and SCD. The follicle densities were within the 95% prediction interval of the reference group in all cases. A similar expression of six proteins essential for follicular health was detected using immunohistochemistry in BT, SCD, and references. OTC should be considered an option for young girls and adolescents with BT and SCD. |
topic |
ovarian tissue cryopreservation fertility preservation thalassemia sickle cell disease genetic diseases |
url |
https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/full |
work_keys_str_mv |
AT linnsaltomamsen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT stinegrykristensen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT susanneelisabethpors consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT janealrøbøtkjær consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT erikernst consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT kirstentrydemacklon consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT debragook consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT debragook consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT ajaykumar consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT bhanukalra consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved AT clausydingandersen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved |
_version_ |
1724337111562190848 |